Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$9.872M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
1002.44%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
12.99M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$8.762M

Stock Price

Loading...
Market Cap: $4.1429 Million

About Revelation Biosciences Inc

Revelation Biosciences Inc (NASDAQ: REVB) is a biosciences company listed on the Nasdaq Stock Market. The single available filing excerpt does not contain sufficient operational or financial detail to describe the company's core business activity, revenue model, product portfolio, customer base, or competitive position. The 10-K filed 2026-02-26 (accession 000119312526076552) provides only cover-page registration data, including a note that the company has redeemable warrants exercisable for shares of common stock. No revenue figures, pipeline assets, therapeutic areas, or business descriptions are supported by the excerpts provided. A complete description cannot be generated without additional filing content.

Source: SEC 10-K, filed 2026-02-26

Industry: Pharmaceutical Preparations Peers: Fresh Tracks Therapeutics, Inc. Panbela Therapeutics, Inc. CONTRAFECT Corp Creative Medical Technology Holdings Inc NUTRA PHARMA CORP Kiromic Biopharma, Inc. MANHATTAN SCIENTIFICS INC Dogwood Therapeutics Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support